Batswadi Pharmaceuticals

Batswadi Pharmaceuticals (PTY) Ltd is a newly established black empowered, innovative company with a focus on biotechnology, founded to leverage the unmet needs of the South African pharmaceutical market.

Founded in the spring of 2005 by CEO, Christopher Whitfield, Batswadi (meaning parent in Tswana) aims to increase Africa’s access to innovative products, diagnostics, devices and services.

To ensure that it achieves these aims, it has entered into strategic partnerships with key players that will not only see it deliver economic benefits to its shareholders but simultaneously increase the African people’s access to innovative products and technologies.

Its four core business units: pharmaceutical sales, biotechnology, clinical research and consumer health, are staffed by a team of highly skilled individuals who are dedicated to ensuring the highest levels of excellence in the execution of its strategic intent.

LaGray Pharmaceuticals

Africa is in need of cheap and effective pharmaceuticals. LaGray is the first fully-integrated generic pharmaceutical manufacturer in West Africa. They produce both active pharmaceutical ingredients and finished dosage forms.

Their focus is on drugs for treating endemic diseases such as HIV-AIDS, opportunistic infections, malaria, tuberculosis and parasitic, bacterial and fungal infections.

They have received funding from the World Bank and OPIC of the US government. The founders have made it known that they are in need of more funding to expand their operations.

Please check out their site and see this remarkable pharmaceutical company.